Production method of virus-inactivated plasma for treating COVID-19

The invention relates to a production method of virus-inactivated plasma for treating COVID-19. The method comprises the following steps: (1) collecting convalescent plasma of COVID-19 survivors or plasma immune to a Severe Acute Respiratory Syndrome Coronavirus 2 vaccine (SARS-CoV-2 vaccine), and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GONG QIN, YUE SHENGLAN, ZOU HAOYONG, LU ZHONGQUAN, YANG XIAOMING, HU YONG, ZHENG XIAOBEI, YU DING, HAN REN, SI SHIHONG, WANG YUE, DENG KUN, JIA LING, YANG HUICHUAN, LIN LIANZHEN, LI CESHENG, LIU CHUNJIE, HE YANLIN, XING YANTAO, ZHAN QIAN, PAN XIAOMING, ZHOU DONGBO, DENG ZHIJUN, PENG YAN, CHEN KEJIN, ZHU CHEN, DUAN KAI, LIU ZHIPENG, LIU YING, FENG LU, XIE YONG, WU XIAO, LI TAOJING, ZHOU ZHIJUN, LIANG XIAOLONG, HOU YONG, YU JIANHONG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a production method of virus-inactivated plasma for treating COVID-19. The method comprises the following steps: (1) collecting convalescent plasma of COVID-19 survivors or plasma immune to a Severe Acute Respiratory Syndrome Coronavirus 2 vaccine (SARS-CoV-2 vaccine), and conducting pretreatment; (2) adding methylene blue, and conducting photo-inactivation on the plasma;and (3) conducting labeling and packaging after the plasma passes tests. 本发明涉及一种治疗COVID-19的病毒灭活血浆的制备方法,所述方法包括如下步骤:(1)采集COVID-19康复者恢复期血浆或经新型冠状病毒疫苗(SARS-CoV-2疫苗)免疫后血浆及预处理;(2)添加亚甲蓝,并对血浆进行光照灭活;(3)检测合格后贴标包装。